The key change is that GMP inspection outcomes will become publicly visible, rather than remaining information communicated primarily between the TGA and the inspected manufacturer. ...more
Therapeutic Goods Administration ,GMP
November 01, 2026•11 min read

Recognising that some organisations may require additional time to complete implementation, the TGA has introduced a streamlined UDI Consent to Supply process commencing on 1 July 2026. ...more
Therapeutic Goods Administration
July 06, 2026•5 min read

The TGA compliance principles are grounded in scientific rigor, risk-based thinking, and lifecycle control of therapeutic goods. ...more
Therapeutic Goods Administration
May 13, 2026•6 min read

Therapeutic goods manufacturers face a complex and evolving regulatory landscape, with challenges spanning quality management, data integrity, validation, and supply chain oversight. While these chall... ...more
Therapeutic Goods Administration
April 22, 2026•6 min read

The proposed changes to medicine labelling requirements in Australia represent a significant regulatory update aimed at improving safety, clarity, and consistency across therapeutic goods. ...more
Therapeutic Goods Administration
April 08, 2026•5 min read

The TGA’s "Educate to Empower" initiative, as outlined in the 2026–2027 Compliance Principles, provides a robust framework for supporting therapeutic goods organisations in regulatory compliance. ...more
Therapeutic Goods Administration ,Quality Training
February 23, 2026•4 min read

Resources: QSN Academy · Blog · Webinars · eBooks · Scorecards · Book
Connect: LinkedIn (QSN) · LinkedIn (QSN Academy) · Linkedin (Dr Kathy Walsh) · Facebook · Email at info@qualitysystemsnow.com.au · Contact Us
Legal: Privacy Policy · Terms & Conditions · Complaints Procedure · Sitemap · QSN ABN 42 621 334 754